Get the Stockscreener App
1.89
0.53%
-0.01
Matinas Biopharma Holdings Inc stock is traded at $1.89, with a volume of 35,182.
It is down -0.53% in the last 24 hours and up +3.85% over the past month.
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. The company enables the delivery of life-changing medicines using its lipid nano-crystal (LNC) platform technology. Its LNC delivery technology platform utilizes lipid nano-crystals which can encapsulate small molecules, oligonucleotides, vaccines, peptides, proteins and other medicines potentially making them safer, more tolerable, less toxic, and orally bioavailable. The company's lead anti-fungal product candidate is MAT2203, an orally-administered cochleate formulation of amphotericin B that has completed Phase II clinical trials for the prevention of invasive fungal infections due to immunosuppressive therapy in patients with acute lymphoblastic leukemia. Its product candidates also comprise MAT2501, an orally administered cochleate formulation of the broad spectrum aminoglycoside antibiotic amikacin that has completed Phase I clinical trials to treat various types of multidrug-resistant bacteria, including non-tuberculous mycobacterium infections, as well as various multidrug-resistant gram negative and intracellular bacterial infections. The company was founded in 2013 and is based in Bedminster, New Jersey.
See More
Previous Close:
$1.90
Open:
$1.96
24h Volume:
35,182
Relative Volume:
0.08
Market Cap:
$9.61M
Revenue:
-
Net Income/Loss:
$-21.13M
P/E Ratio:
-0.3946
EPS:
-4.79
Net Cash Flow:
$-16.95M
1W Performance:
-2.58%
1M Performance:
+3.85%
6M Performance:
+263.46%
1Y Performance:
-46.61%
1-Day Range:
$1.8519
$1.99
1-Week Range:
$1.83
$2.02
52-Week Range:
$0.4748
$4.25
Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile
Name
Matinas Biopharma Holdings Inc
Sector
Industry
Phone
908-443-1860
Address
1545 Route 206 South, Suite 302, Bedminster, NJ
Compare MTNB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MTNB
Matinas Biopharma Holdings Inc
|
1.89 | 10.55M | 0 | -21.13M | -16.95M | -4.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-11-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-26-20 | Resumed | Piper Sandler | Overweight |
| Jan-27-20 | Initiated | Piper Sandler | Overweight |
| Jan-24-20 | Initiated | SunTrust | Buy |
| Jan-23-20 | Initiated | SunTrust | Buy |
| Jan-09-20 | Initiated | Aegis Capital | Buy |
| Jun-26-19 | Initiated | H.C. Wainwright | Buy |
View All
Matinas Biopharma Holdings Inc Stock (MTNB) Latest News
Why institutional investors increase stakes in Matinas Biopharma Holdings Inc. stock2025 Support & Resistance & High Conviction Buy Zone Picks - newser.com
Will Matinas BioPharma Holdings Inc. stock return to pre crisis levelsPrice Action & Precise Trade Entry Recommendations - newser.com
Will Matinas BioPharma Holdings Inc. stock outperform international peersJuly 2025 Catalysts & Scalable Portfolio Growth Ideas - newser.com
How high can Matinas BioPharma Holdings Inc. stock goPortfolio Performance Summary & Real-Time Sentiment Analysis - newser.com
Is Matinas Biopharma Holdings Inc. stock undervalued historicallyWeekly Trend Recap & Community Verified Swing Trade Signals - newser.com
Will Matinas Biopharma Holdings Inc. stock keep high P E multiplesJuly 2025 Update & Consistent Return Strategy Ideas - newser.com
Why Matinas BioPharma Holdings Inc. stock is in analyst buy zone2025 Earnings Impact & Fast Moving Trade Plans - newser.com
Will Matinas Biopharma Holdings Inc. stock test record highs in 20252025 Price Action Summary & Fast Entry and Exit Trade Plans - newser.com
Why millennials buy Matinas BioPharma Holdings Inc. (6LJ0) stockJuly 2025 Sentiment & AI Based Buy/Sell Signal Reports - newser.com
Why Matinas BioPharma Holdings Inc. (6LJ0) stock gets analyst attentionDip Buying & Technical Confirmation Trade Alerts - newser.com
What dividend safety rating applies to Matinas BioPharma Holdings Inc. (6LJ0) stockJuly 2025 Setups & High Yield Equity Trading Tips - newser.com
Ranking Matinas BioPharma Holdings Inc. among high performing stocks via toolsJuly 2025 PreEarnings & Real-Time Volume Trigger Notifications - newser.com
How to build a custom watchlist for Matinas BioPharma Holdings Inc.Trend Reversal & Capital Protection Trade Alerts - newser.com
Can trapped investors hope for a rebound in Matinas BioPharma Holdings Inc.Quarterly Market Review & Long Hold Capital Preservation Plans - newser.com
Understanding Matinas BioPharma Holdings Inc.’s price movementEarnings Risk Report & Real-Time Volume Spike Alerts - newser.com
What to expect from Matinas BioPharma Holdings Inc. in the next 30 daysJuly 2025 Sector Moves & Reliable Entry Point Alerts - newser.com
Why retail traders accumulate Matinas BioPharma Holdings Inc. (6LJ0) stockEarnings Overview Report & Low Drawdown Trading Techniques - newser.com
How Matinas Biopharma Holdings Inc. stock moves in volatile trading sessions2025 Buyback Activity & Expert Verified Stock Movement Alerts - newser.com
Can Matinas BioPharma Holdings Inc. stock attract ESG capital inflowsJuly 2025 Institutional & Real-Time Chart Pattern Alerts - newser.com
Is Matinas BioPharma Holdings Inc. stock a dividend growth opportunity - newser.com
Will Matinas Biopharma Holdings Inc. stock outperform energy sector in 2025Weekly Investment Recap & Entry Point Confirmation Alerts - newser.com
What drives Matinas BioPharma Holdings Inc stock priceTrendline Breakouts & High Return Stock Ideas - earlytimes.in
Matinas BioPharma Holdings Inc 6LJ0 Stock Analysis and ForecastTrading Volume Surges & Double Or Triple Profits - earlytimes.in
Matinas Biopharma Holdings Inc Stock (MTNB) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.36%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):